mirabegron has been researched along with Prostatic-Diseases* in 3 studies
2 trial(s) available for mirabegron and Prostatic-Diseases
| Article | Year |
|---|---|
Editorial Comment from Dr Matsuo et al. to Mirabegron for treatment of erectile dysfunction concomitant with lower urinary tract symptoms in patients with benign prostatic obstruction: A randomized controlled trial.
Topics: Acetanilides; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Prostatic Diseases; Thiazoles | 2022 |
Editorial Comment from Dr Funahashi to Mirabegron for treatment of erectile dysfunction concomitant with lower urinary tract symptoms in patients with benign prostatic obstruction: A randomized controlled trial.
Topics: Acetanilides; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Prostatic Diseases; Thiazoles | 2022 |
1 other study(ies) available for mirabegron and Prostatic-Diseases
| Article | Year |
|---|---|
Adding Mirabegron to Solifenacin to Treat Overactive Bladder Has Little Impact on Postvoid Residual Volume or Urinary Retention Risk.
Topics: Acetanilides; Adult; Aged; Aged, 80 and over; Catheterization; Cohort Studies; Female; Humans; Incidence; Male; Middle Aged; Muscarinic Antagonists; Prostatic Diseases; Randomized Controlled Trials as Topic; Residual Volume; Risk; Solifenacin Succinate; Thiazoles; Treatment Outcome; Urinary Bladder, Overactive; Urinary Retention; Urodynamics; Urological Agents | 2017 |